Tag: FDA Adverse Event Reporting System
Medications
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA monitors generic drugs after approval using real-world data, adverse event reports, and AI tools to catch safety issues that clinical trials miss. Learn how FAERS, Sentinel, and inspections keep generics safe.
